

Prolia 60mg Injection (Denosumab)
Manufactured By
Dr. reddys laboratories ltd
Pack Of
1
Salt Composition
Denosumab
Storage
Keep in cold place
Overview
Prolia 60mg Injection contains Denosumab as an active ingredient that is a monoclonal antibody. Doctor prescribes it to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It makes the bones strong as well as reduces the risk of fractures. It works by binding to a protein that causes bone loss, thereby strengthening the bone and minimizing the risk of fractures. It should be given by healthcare professional only do not self administer this injection.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | prolia |
| Generic / Active Ingredient | Denosumab |
| Strength | 60 |
| Dosage Form | Injection |
| Manufacturer / Marketer | dr. reddys laboratories ltd |
| Pack Size | 1 |
| Prescription Required | Yes |
| Therapeutic Categories | Cancer Medicines |
| Uses | Multiple Myeloma |
Uses and Indications
Multiple myeloma
Side Effects of Prolia 60mg Injection
Every medicine has some side effects that manage on their own as your body gets used to the medicine, but some people may rarely experience severe side effects. In that case, the patient should contact the doctor immediately.
Some common side effects of Prolia 60mg Injection(Denosumab 60mg) include:
● Rash
● Musculoskeletal (bone, muscle or joint) pain
● Eczema
● Upper respiratory tract infection
● Sciatica
● Pain in extremities
● Back pain
● Joint pain
● Urinary tract infection
● Constipation
● Abdominal discomfort
● Hair loss
● Hypercholesterolemia (high cholesterol)
● Cystitis
● Nerve pain
● Headache
Prolia 60mg Injection Dosage and How To Take It
Prolia 60mg Injection(Denosumab 60mg) is a powerful monoclonal antibody. that can only be given by a doctor or nurse under strict medical supervision. It is not self-administerable. Dosage and duration of the treatment are determined by the doctor as per the patient's health condition and type of the disease.
Safety Advice for Prolia 60mg Injection
- ● Alcohol: Avoid the consumption of alcohol while taking Prolia 60mg Injection(Denosumab 60mg), as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
- ● Pregnancy: Do not take the Prolia 60mg Injection without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
- ● Breastfeeding: Breastfeeding women should discuss the potential risks and benefits of the Prolia 60mg Injection(Denosumab 60mg) with their healthcare provider before starting treatment.
- ● Driving: Prolia 60mg Injection is usually consider safe in case of driving as it does not affect your ability to drive.
- ● Kidney: Consumption of Prolia 60mg Injection(Denosumab 60mg) should be avoided without informing the doctor if you have any kidney-related issues.
- ● Liver: Consumption of Prolia 60mg Injection(Denosumab 60mg) should be avoided without informing the doctor if you have any liver-related issues.
FAQs About Prolia 60mg Injection
What are the common side effects of Prolia 60mg Injection(Denosumab 60mg)?
There are some common yet manageable side effects of taking Prolia 60mg Injection that include pain in extremities, back pain, joint pain, urinary tract infection, constipation, etc.
Is it safe to take the Prolia 60mg Injection during pregnancy or breastfeeding?
Consumption of Prolia 60mg Injection(Denosumab 60mg) during pregnancy is considered to be unsafe and safe during breastfeeding. However, it is necessary to consult with a doctor in both cases.
What are the uses of Prolia 60mg Injection?
Prolia 60mg Injection is a monoclonal antibody used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures.
How does Prolia 60mg Injection(Denosumab 60mg) work?
Prolia 60mg Injection works by binding to a protein that causes bone loss, thereby strengthening the bone and minimizing the risk of fractures.
How to take Prolia 60mg Injection?
Prolia 60mg Injection(Denosumab 60mg) should be given by healthcare professional only do not self administer this injection.
References
● Svendsen, O. L. (2023). Treatment of osteoporosis with denosumab in patients with decreased kidney function. Archives of Osteoporosis, 18(1), 104.
● Belavic, J. M. (2011). Denosumab (Prolia): a new option in the treatment of osteoporosis. The Nurse Practitioner, 36(1), 11-12.
● Li, R., Yuan, X., Chen, X., Ou, Y., & Chen, J. (2024). Analysis of adverse drug reactions of Denosumab (Prolia) in osteoporosis based on FDA adverse event reporting system (FAERS). Frontiers in Pharmacology, 15, 1358592.
● Skripnikova, I. A., Kosmatova, O. V., Abirova, E. S., Novikov, V. E., & Murashko, L. M. (2017). Experience in using Prolia in patients with postmenopausal osteoporosis in clinical practice. Terapevticheskii arkhiv, 89(12-2), 190-196.
● Green, W. (2010). Denosumab (Prolia) injection: a new approach to the treatment of women with postmenopausal Osteoporosis. Pharmacy and therapeutics, 35(10), 553.
Marketer Details
Dr. reddys laboratories ltd
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.


